2B7J:F:F-iShares MSCI World SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 8.263

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.25 (-0.96%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.34 (-0.67%)

USD 115.48B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 88.54B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.25 (-1.16%)

USD 75.49B
EUNL:F iShares Core MSCI World UCITS ..

+0.50 (+0.54%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 56.16B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.33 (-2.20%)

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.63 (+0.66%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.86 (+0.90%)

USD 51.63B

ETFs Containing 2B7J:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.51% 59% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.51% 56% F 56% F
Trailing 12 Months  
Capital Gain 23.20% 83% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.20% 80% B- 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.73% 56% F 59% D-
Dividend Return 3.73% 55% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.21% 74% C 91% A-
Risk Adjusted Return 51.65% 70% C- 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike